Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Laekna, Inc. ( (HK:2105) ) has shared an update.
Laekna, Inc. has announced that its board of directors will convene on March 24, 2025, to review and approve the company’s annual financial results for the year ending December 31, 2024. This meeting is significant for stakeholders as it will provide insights into the company’s financial health and operational performance, potentially impacting its market positioning and investor confidence.
More about Laekna, Inc.
Laekna, Inc. is a company incorporated in the Cayman Islands with limited liability, and its stock is listed on the Stock Exchange of Hong Kong. The company operates in the pharmaceutical industry, focusing on the development and commercialization of innovative therapies.
YTD Price Performance: 57.31%
Average Trading Volume: 8,087,589
Technical Sentiment Consensus Rating: Sell
Learn more about 2105 stock on TipRanks’ Stock Analysis page.